UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

BMC cancer, 2024-07, Vol.24 (1), p.1-13, Article 823

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation

Clinical pharmacokinetics, 2024-07, Vol.63 (7), p.945-964

2024

Link zum Volltext

Verfügbarkeit prüfen

Participants’ perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study

BMC cancer, 2024-07, Vol.24 (1), p.1-10, Article 802

2024

Link zum Volltext

Verfügbarkeit prüfen

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Nature communications, 2024-07, Vol.15 (1), p.5661-18, Article 5661

2024

Link zum Volltext

Verfügbarkeit prüfen

Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study

BMC cancer, 2024-07, Vol.24 (1), p.1-8, Article 833

2024

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review

BMC cancer, 2024-07, Vol.24 (1), p.1-15, Article 826

2024

Link zum Volltext

Verfügbarkeit prüfen

Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

Breast cancer research : BCR, 2024-07, Vol.26 (1), p.1-14, Article 111

2024

Link zum Volltext

Verfügbarkeit prüfen

Open Versus Closed Negative Pressure Wound Therapy For Contaminated and Dirty Surgical Wounds: A Quasi-Experimental Study

Pakistan Armed Forces medical journal, 2024-06, Vol.74 (3), p.731-735

2024

Link zum Volltext

Verfügbarkeit prüfen

Private Health Management Advocates for Better Use of Clinical Trials

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Life Sciences Firms Adopt Tools to Modernize Clinical Trials

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Antidote Partners with SEQSTER to Accelerate Patient Identification Enrollment for Clinical Trials

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

KOLON TISSUEGENE COMPLETES PATIENT DOSING IN TWO PIVOTAL US PHASE III CLINICAL TRIALS FOR TG-C

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Beyond Celiac Coalition and FDA Discuss Major Patient Barriers to Accelerate Clinical Trials for Celiac Disease

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Hoth Therapeutics Expands Clinical Trial for Cancer Patients

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

First Patient Dosed in Phase I Clinical Trial of YOLT-201

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrollment

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

cTAP Study Indicates Duchenne Muscular Dystrophy Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase

Business Wire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

First Type 1 Diabetes Patient Enrolled in Rise Therapeutics' Latest Clinical Trial

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Lindus Health and Aktiia to launch observational clinical trial for Aktiia's Optical Blood Pressure Monitoring Device

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

Highlands and Paradigm improve access to cancer care options in northwest Arkansas, increasing clinical trial participation by 45

PR Newswire, 2024

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 30 Tagen

KollektionNexis Uni

ThemaClinical Trials

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(11)

Publikationsform

Newsletter-Artikel
(65)
Artikel
(12)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Bmc Cancer
(5)
Nature Communications
(2)
Breast Cancer Research : Bcr
(1)
Clinical Pharmacokinetics
(1)
Ophthalmology Times
(1)
Pakistan Armed Forces Medical Journal
(1)
Renal & Urology News
(1)

2 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation

Participants’ perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review

Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

Open Versus Closed Negative Pressure Wound Therapy For Contaminated and Dirty Surgical Wounds: A Quasi-Experimental Study

Private Health Management Advocates for Better Use of Clinical Trials

Life Sciences Firms Adopt Tools to Modernize Clinical Trials

Antidote Partners with SEQSTER to Accelerate Patient Identification Enrollment for Clinical Trials

KOLON TISSUEGENE COMPLETES PATIENT DOSING IN TWO PIVOTAL US PHASE III CLINICAL TRIALS FOR TG-C

Beyond Celiac Coalition and FDA Discuss Major Patient Barriers to Accelerate Clinical Trials for Celiac Disease

Hoth Therapeutics Expands Clinical Trial for Cancer Patients

First Patient Dosed in Phase I Clinical Trial of YOLT-201

Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184

Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrollment

cTAP Study Indicates Duchenne Muscular Dystrophy Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status

Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase

First Type 1 Diabetes Patient Enrolled in Rise Therapeutics' Latest Clinical Trial

Lindus Health and Aktiia to launch observational clinical trial for Aktiia's Optical Blood Pressure Monitoring Device

Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma

Highlands and Paradigm improve access to cancer care options in northwest Arkansas, increasing clinical trial participation by 45

Aktive Filter

Suchergebnisse filtern